#Global Trends – Page 30 – HEALTHCARE INSIGHTS

Key Development China's National Healthcare Security Administration (NHSA) has officially released its updated regulatory ledger showing that next-generation GLP-1 receptor... Read more

Tag: #Global Trends

Late-Stage Asset Crystallization: Analyzing Ipsen’s $1.7 Billion Strategic Acquisition of Kartos Therapeutics

The GLP-1 Warfare in China: Pfizer and Innovent Clear Preliminary National Insurance Hurdles for a Billion-Citizen Market

Disrupting the Genomics Monopoly: Analyzing Roche’s Strategic Deployment of Axelios to Challenge Illumina

Accelerating the Onshoring Wave: FDA Enrolls Eli Lilly and Regeneron in Landmark Real-Time Construction Review Pilot

Quality Risk Governance: Analyzing Amgen’s Nationwide Recall of 1 Million Corlanor and Sensipar Bottles in the U.S.

Chemistry, Manufacturing, and Controls Bottlenecks: Analyzing the FDA’s Complete Response Letter for Sobi’s Gout Biologic

Reversing Corporate Criminal Exposure: US DOJ Closes Criminal Investigation into Abbott Over Baby Formula Plant Missteps

Clinical Data Integrity Collapses: Analyzing EMA’s Recommendation to Revoke Amgen’s Orphan Drug Authorization for Tavneos

The GLP-1 Warfare in China: Pfizer and Innovent Clear Preliminary National Insurance Hurdles for a Billion-Citizen Market

Facebook

Map

Online Members